The Latest

  • Close up of a robotic arm above several lines of test tubes, with people looking in through a glass window.
    Image attribution tooltip
    Courtesy of Ambry Genetics
    Image attribution tooltip

    Tempus AI to buy genetic testing company for $600M

    CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing business.

  • Portrait of Michelle Brennan
    Image attribution tooltip
    Permission granted by Politan Capital Management
    Image attribution tooltip

    Masimo, amid leadership transition, targets cost reductions

    Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not spun off.

  • A person in scrubs and gloves holds an image of a mammogram above a lighted panel
    Image attribution tooltip
    Thomas Andreas via Getty Images
    Image attribution tooltip

    Advamed asks CMS to cover extra imaging of dense breast tissue

    Many patients with dense breast tissue currently have to pay out of pocket or forgo potentially life-saving additional testing, Advamed said in a letter.

  • A coil-shaped device is shown moving through a tube with branching structures around it.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic, Recor win CMS transitional payment coverage for renal denervation devices

    Patient and physician education is the next challenge to change the treatment paradigm for drug-resistant hypertension, Citi Research analyst Joanne Wuensch said.

  • A building in front of a pond with the sign "Medtronic" on a stone wall.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Baxter, Medtronic, Insulet to wrap up medtech earnings

    Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation device.

  • A headshot of Mojdeh Paul against with a window and white wall in the background.
    Image attribution tooltip
    Courtesy of Integra LifeSciences Holdings Corporation
    Image attribution tooltip

    Integra Lifesciences names Mojdeh Poul as CEO

    Poul will take over the company in January after spending 11 years with 3M and working at Medtronic and Boston Scientific.

  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific continues M&A run with Cortex buy

    Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ablation devices.

  • A doctor puts a pulse oximeter on a patient's finger
    Image attribution tooltip
    Wavebreakmedia via Getty Images
    Image attribution tooltip

    Medtronic settles pulse oximetry lawsuit alleging inaccuracies

    Roots Community Health has sued 12 other firms, including GE Healthcare, CVS and Walgreens, and called for manufacturers and the FDA to ensure the devices work for everyone.

  • Brain scans
    Image attribution tooltip
    iStock via Getty Images
    Image attribution tooltip

    Zimmer licenses NeuroOne brain ablation system

    NeuroOne will get $3 million upfront for an exclusive license to distribute its radiofrequency ablation system designed to treat neurological disorders such as epilepsy and Parkinson's disease.

  • The European Union flag.
    Image attribution tooltip
    artJazz via Getty Images
    Image attribution tooltip

    EU posts guidance on ethylene oxide in device sterilization

    The document clarifies that EtO falls within the scope of the Medical Device Regulation and the In Vitro Diagnostic Regulation.

  • iRhythm's Zio AT cardiac monitor is shown against a white background.
    Image attribution tooltip
    Retrieved from iRhythm on October 22, 2024
    Image attribution tooltip

    FDA clears iRhythm’s second 510(k) in response to warning letter

    However, the company said it will delay a submission for its next-generation Zio cardiac monitoring system until remediation efforts are further along.

  • Professional photo of Larry Jones
    Image attribution tooltip
    Permission granted by Johnson & Johnson
    Image attribution tooltip

    J&J Medtech CIO Larry Jones resigns

    Jones, who has led connectivity solutions for J&J’s surgical robots, announced his departure on LinkedIn.

    Updated Nov. 1, 2024
  • A person speaks at a podium.
    Image attribution tooltip
    Elise Reuter/MedTech Dive
    Image attribution tooltip

    Michelle Tarver faces challenges as new CDRH leader. But patient groups, industry are optimistic.

    Patient advocates are hoping for change under new director Michelle Tarver, while industry groups look to build on former director Jeff Shuren’s leadership.

    FDA
  • A stage at HLTH 2024.
    Image attribution tooltip
    Emily Olsen/MedTech Dive
    Image attribution tooltip
    Deep Dive

    Tech companies pitch AI platforms for healthcare, outline plans for responsible rollout

    Google, Microsoft and GE Healthcare say they’ll power the next wave of AI advancement. But executives are split on how to offer the tools to providers responsibly — and whether all clinicians are equally ready for them.

  • Boston Scientific's Acurate neo2 TAVR device is shown close up against a white background.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific’s Acurate Neo2 inferior to rival TAVR valves in study

    Analysts said the findings complicate the outlook for a U.S. launch of Boston Scientific's aortic valve replacement device.

  • A view of the Edwards Lifesciences headquarters building with three people walking in front.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards, Medtronic and Inari share trial data at TCT conference

    The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the companies and their device markets.

  • The exterior of a U.S. Bankruptcy Courthouse.
    Image attribution tooltip
    GussWilder for iStock via Getty Images
    Image attribution tooltip

    Exactech files for Chapter 11, agrees to investor buyout

    The filing follows Exactech’s failure to settle product liability claims from about 2,600 patients in response to recalls of orthopedic devices.